{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T18:57:12Z","timestamp":1776538632150,"version":"3.51.2"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Systemic Epstein-Barr virus\u2013positive T-cell lymphoma of childhood (S-EBV-TCL) is a rare disease for which there is no standard of care. S-EBV-TCL is often associated with hemophagocytic lymphohistiocytosis and is generally thought of on the spectrum of EBV-related disease. For the few reported cases of cure in the literature, hematopoietic stem cell transplant has been required because it is the only treatment that has induced complete remission in patients suffering from EBV-associated T-cell or natural killer cell lymphoproliferative diseases, except hemophagocytic lymphohistiocytosis. Here, we present the case of one patient who was successfully cured with a modified regimen of dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin), followed by hematopoietic stem cell transplant using a reduced-intensity conditioning regimen.<\/jats:p>","DOI":"10.1097\/mph.0000000000002800","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T09:07:23Z","timestamp":1703063243000},"page":"e208-e211","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Hematopoietic Bone Marrow Transplant to Treat Systemic EBV-positive T-cell Lymphoma of Childhood"],"prefix":"10.1097","volume":"46","author":[{"given":"Nicholas","family":"Manini","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Davidow","sequence":"additional","affiliation":[{"name":"Department of Pathology Division of Pediatric Hematology\/Oncology, Nemours Center for Cancer and Blood Disorders, Nemours Children\u2019s Hospital\u2014Delaware, Wilmington, DE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Conard","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/oncology Pathology, Nemours Children\u2019s Hospital\u2014Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Powell","sequence":"additional","affiliation":[{"name":"Department of Pathology Division of Pediatric Hematology\/Oncology, Nemours Center for Cancer and Blood Disorders, Nemours Children\u2019s Hospital\u2014Delaware, Wilmington, DE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/aol-21-33","article-title":"From pathobiology to targeted treatment in Epstein Barr virus related T cell and Natural Killer cell lymphoproliferative diseases","volume":"5","author":"Glover","year":"2021","journal-title":"Ann Lymphoma"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1752-1947-5-218","article-title":"Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: a case report and review of the literature","volume":"5","author":"Tabanelli","year":"2011","journal-title":"J Med Case Rep"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-Barr-virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/10428194.2019.1699080","article-title":"Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting","volume":"61","author":"Cohen","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","article-title":"How I treat T-cell chronic active Epstein-Barr virus disease","volume":"131","author":"Bollard","year":"2018","journal-title":"Blood"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/08880018.2018.1459982","article-title":"Successful treatment of systemic EBV positive T-cell lymphoma of childhood using the SMILE regimen","volume":"35","author":"Yoshida","year":"2018","journal-title":"Pediatr Hematol Oncol"},{"key":"R7-20250804","first-page":"177","article-title":"Systemic Epstein\u2013Barr virus\u2010positive T\u2010cell lymphoma of childhood treated with the ice regimen and allogeneic hematopoietic stem\u2010cell transplantation","volume":"70","author":"Nagahama","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK\u2013cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1182\/blood-2018-01-828277","article-title":"Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies","volume":"132","author":"Allen","year":"2018","journal-title":"Blood"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1111\/bjh.16370","article-title":"Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH","volume":"188","author":"Naik","year":"2020","journal-title":"Br J Haematol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families","volume":"38","author":"Yang","year":"2020","journal-title":"J Clin Oncol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"e27798","DOI":"10.1002\/pbc.27798","article-title":"A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: a single tertiary care pediatric institution experience in North America","volume":"66","author":"Coffey","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1056\/NEJMc2020754","article-title":"Emapalumab in primary hemophagocytic lymphohistiocytosis","volume":"383","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:05:05Z","timestamp":1754337905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002800","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"2023-07-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}